From SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot:

SQZ

SQZ—

SQZ Biotechnologies squeezes cells to open their membrane, allowing a protein or other material to enter. Image courtesy of SQZ.

Underwriters and Partners

Xconomy Insight

From Our Editors · Podcast
Xcelerating Life Sciences Philadelphia: The Highlights Podcast
Becoming the Cell & Gene Therapy Hub

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Webinar
Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX

Xconomy on Demand

We offer a number of ways to subscribe for free!